Frazier Lifesciences Acquisition Corp
SEC CIK 1828326 · FLAC · last insider filing 2022-11-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bigham Michael | Director | filed 2020 - 2022 |
| Gallagher Carol Giltner | Director | filed 2020 - 2022 |
| Baltera Robert Jr. | Director | filed 2020 - 2022 |
| Polu Krishna R | Director | filed 2020 - 2022 |
| Topper David Joseph | Director · Chief Financial Officer | filed 2020 - 2022 |
| Topper James N | Director · Chief Executive Officer | filed 2020 - 2020 |
| Heron Patrick J | Director | filed 2020 - 2020 |
| Fhmls X, L.L.C. | Director | filed 2020 - 2020 |
| Frazier Life Sciences X, L.P. | Director | filed 2020 - 2020 |
| Fhmls X, L.P. | Director | filed 2020 - 2020 |
| Frazier Lifesciences Sponsor LLC | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Nowicki Max N. | Vice President, Acquisitions | filed 2020 - 2020 |
| Empey Gordon | Vice President&General Counsel | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.